---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-209709"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T22:01:03.107107+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q1 revenue up 21% to $403.5M; net income $14.2M; raises FY guidance

## Summary
- Revenue $403.5M (+21% YoY); net income $14.2M vs $0.7M; Adjusted EBITDA $51.1M (+48%).
- Clinician base up 11% to 8,349 (net +309); visit volumes up 18% to 2.5M.
- Center Margin $135.9M (33.7% of revenue) vs $109.8M (33.0%).
- FY2026 guidance raised: revenue $1.64B-1.68B, Adj EBITDA $200M-220M; Q2 rev $405M-425M.
- Free cash flow $22.3M; cash $194.8M; net debt $262.5M.

## SEC filing metadata
- accession: 0001193125-26-209709
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000119312526209709/0001193125-26-209709-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000119312526209709/lfst-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-209709
- JSON: https://secwatch.observer/filing/0001193125-26-209709.json
- Plain text: https://secwatch.observer/filing/0001193125-26-209709.txt

## Source-grounded claims
- claim_id: 672fb2ca9af31560131be2bb0402d4078f201945
  claim: LifeStance Health Group, Inc. reported the first quarter ended March 31, 2026 results: revenue $403.5 million, net income $14.2 million. Guidance raised.
  evidence_excerpt: for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000119312526209709/0001193125-26-209709-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.